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In a  former communication (I)  we reported that the action of 
ethylhydrocuprein (a derivative of hydroquinine introduced by Mor- 
genroth and  Levy  (2))  was well marked in vitro  and in vivo  on 
type strains of the four groups of pneumococci.  Since we possess 
in certain types of antipneumococcus serum the means of conferring 
on experimental animals considerable specific protection against very 
many multiples of the minimal lethal dose of a virulent pneumococ- 
cus culture, it seemed to us of interest to study the combined effect 
of  chemo- and  serotherapy in vivo,  and to  endeavor to  get  some 
numerical values representing the results. 
Neufeld  (3)  showed  that  strains  of  pneumococci  differed  among  themselves 
in  respect  to  their  immunity  reactions  (protective  antibodies). 
The  work  of  Cole  (4)  and  of  Dochez  and  Gillespie  (5)  has  resulted  in  a 
serological classification of the pneumococci.  The pneumococci can be divided into 
at  least  four groups;  an  immune  serum produced  against  any member  of  Group 
I  has a  specific agglutinative action upon,  and  a  specific protective action against, 
any  member  of  Group  I,  but  has  no  such  effects  on  any  member  of  the  other 
three groups.  In  like manner,  an  immune  serum  against  any member of  Group 
II behaves  similarly with  respect  to  any member  of  Group  II,  but  has  no  effect 
on  any  member  of  Groups  I,  III,  or  IV.  To  Group  III  belong  all  the  micro- 
organisms  of  the Pneumococcus  mucosus  type.  To  Group  IV belong  all  those 
strains of pneumococci which do not fall into the other three groups ; an immune 
serum  produced  against  any  member  of  this  group  has  a  specific  agglutinative 
action  upon,  and  a  specific protective action  against,  the  strain  used  for its  pro- 
duction,  but  has  no  such  effects  on  any  other  member  of  this  group,  or  of  the 
other groups. 
Neufeld  and  Engwer  (6)  and  Engwer  (7)  have  studied  the  effect  of  com- 
bining  the  serum  and  chemotherapy  in  guinea  pigs  infected  with  pneumococcal 
pleural  exudates;  these  observers  saw  an  increased  effect by  the  combination. 
Their  protocols  do  not  show,  however,  to  what  group  either  the  pneumococcus 
or  antiserum  belonged;  it  is  not  clear  whether  or  not  the  antiserum  used  was 
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produced  against  a  member  of  the  group  to  which  the  infecting  pneumococcus 
belonged.  Boehncke  (8),  too,  saw  a  markedly  increased  effect  in  mice  by  the 
combination of  serum  and  drug  therapy  over  and  above  the  effect  of  either  of 
these  two  separately;  in  the  protocols  of  his  experiments,  also,  we  have  little 
information as  to  the group  to  which the pneumococct~s  or  antiserum belonged. 
We  deemed it  of  importance to  study the  results  of  combined 
chemotherapy and serum therapy in the light of the serological classi- 
fication of the pneumococci mentioned above; and, since the results 
of serum therapy in man have not been at all as satisfactory in the 
case of lobar pneumonia due to pneumococci belonging to Group II 
as when the disease is caused by a strain of Group I, we have given 
the greater part of our attention,  in this  respect, to  infection with 
pneumococci belonging to  Group II.  Further, the threshold value 
of  our  immune  horse  serum  to  Group  I  is  more  than  ten  times 
greater than the corresponding serum to Group II.  Hence a  satis- 
factory  result  with  an  antiserum  to  Group  II  should  mean  an 
even better result with an antiserum to Group I,  in the case of in- 
fection with a strain of the homologous group. 
Since toxic symptoms have been several times noticed in human 
patients and in experimental animals treated with ethylhydrocuprein, 
we have endeavored to reduce to a  minimum the amount of ethyl- 
hydrocuprein given to the animals in the present study.  The dose 
of ethylhydrocuprein (optochin base)  recommended by Morgenroth 
(9)  in experimental pneumococcal infection in the mouse is o.5  cc. 
of  a  2  per  cent solution  in  olive  oil  given  under  the  skin  of  the 
back immediately following the infection, and repeated on the next 
day; this is  followed on the third day, and on the fourth day if de- 
sirable, by a  similar injection of o.4 cc.  of the same solution.  The 
dosage used in the present study is  considerably below this.  The 
experimental animals used were mice. 
EXPERIMENTAL. 
The strain  of pneumocoecus of Group II  used in  the  present  study 
was a  stock strain and was  maintained in a  condition of maximal 
virulence throughout the experiments ; that is to say, o.ooo,ooi cc. of 
a twenty hour broth culture regularly killed mice within forty-eight 
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experiment.  A twenty hour broth culture of the pneumococcus was 
used in every case.  In the designation of the culture, the Roman 
numeral represents the group to which the pneumococcus belongs, 
the Arabic figure the number of animal passages  which the strain 
had had, and the exponent the number of cultivations on artificial 
media since the last animal passage. 
Mice of 18 grams' weight and upwards were used; the dosage of 
the  drug  was  calculated  in  every  case  according  to  the  weight 
of the  animal.  An autopsy was  performed on every mouse that 
succumbed, unless otherwise stated in the protocols  (owing to the 
body having been eaten by the survivors). 
A constant amount of immune horse serum, o.2 cc., was used in the 
experiments; it was mixed with the infecting dose of culture, and 
the mixture, making a  total volume of  I  cc., was given intraperi- 
toneally. 
The ethylhydrocuprein (optochin base)  was administered in the 
form of a 2 per cent solution in olive oil, given under the skin of the 
back.  This treatment was given, in the first instance, immediately 
Experiment  z.  Titer  of  Antipneumococcus  Serum  //.--(Table  I.)  This 
serum  protected  regularly  against  o.ooI  cc.  of  a  2o  hour  broth  culture  of  any 
strain  of pneumococcus belonging to  Group II. 
TABLE  I. 
Culture II 422; Virulence Maximal. 
Amount  of 
culture. 
C¢. 
0.00  ~ 
,s 
O.OI 
0.02 
Result. 
S 
i, 
,, 
,, 
,4 
,i 
,i 
4, 
•  72 hrs. 
S 
13o 
Amount  of 
culture. 
CO. 
0.02 
0.04 
o.o6 
,i 
,, 
Result. 
•  48 hrs. 
•  60  °' 
S 
•  48  " 
•  24  " 
•  48  " 
•  ,l  ~, 
•  72  " 
•  '*  ,J 
Amount  of 
culture. 
co. 
0.08 
i, 
41 
O.I 
Result. 
•  24 hrs. 
•  ,,  ,4 
•  4~  ,, 
•  ,4  . 
•  .  4, 
148  " 
S 
•  24 
•  *'  ¢, 
•  ,4 
•  48  " 
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after the infection;  if a  second dose was  given it  was  given after 
an interval of 24 hours. 
In the protocols the letter S stands for survival of the correspond- 
ing animal; a  black square  (m)  means death of the animal  from 
pneumococcal septicemia, capsulated diplococci having been found in 
its  .heart's  blood  'by  His's  capsule  stain,  or,  if  this  examination 
proved  negative,  Gram-positive  diplococci  having  been  recovered 
by culture  (abundant inoculation on defibrinated rabbit blood agar) 
from the heart's  blood  at  autopsy.  An oblique  cross  (X)  means 
death of the animal,  the bacteriological examination of the heart's 
blood  (and  peritoneal  cavity,  if  necessary)  by  smear  and  culture 
being negative;  in this case the death of the animal may have been 
due to  fortuitous  influences,  the toxicity of  the  drug,  traumatism 
inflicted in the experiment, etc.  When an autopsy was not possible 
on an animal, its death is indicated by the sign +. 
Comment  on Experiment  ~r.--From the protocol  it  is  seen that, 
while the  intraperitoneal  injection of  0.2  cc.  of  antipneumococcus 
serum II gives to mice a sure protection against o.ooi  cc. of a  viru- 
lent  culture  (Strain  II  425),  this  amount  of  serum  only  gives  a 
very doubtful protection against o.oi, 0.02,  and o.04 cc.  of culture, 
and none at all against 0.06 cc. or more. 
Experiment 2.--Effect of a  single dose of o.45  cc.  and  of a  single dose of 0.5 
cc.,  respectively, of a  2 per cent solution of ethylhydrocuprein  (optochin base)  in 
olive oil per 20 gin. of mouse on pneumococcal infection.  (Table II, Strain II 426.) 
TABLE  II. 
Mouse 
No. 
I 
2 
3 
4 
5 
6 
7 
8 
9 
IO 
II 
I2 
13 
14 
Amount of 
culture. 
CO. 
0.08 
,, 
(( 
¢6 
O.OOI 
O.O00I 
Normal horse 
serum. 
co. 
0.2 
8~ 
Ethylhydrocupreln 
2 per cent solution. 
CO. 
0.45 
~t 
o.5 
2d day. 
Sick 
** 
Sick 
Well 
Sick 
Well 
Result. 
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Comment on Experiment 2.mA single treatment with either 0.45 
cc.  or 0. 5  cc.  of the 2  per cent solution of the drug is without effect 
on the lethal issue due to pneumococcal septicemia,  not alone  when 
the dose of infection  approaches  that used in the  following  experi- 
ments  (0.08  cc.  to 0. 5  cc.),  but also when it is 800 to  5,000  times 
smaller  (o.oooi  cc.). 
Experiment  3.  Combined  Therapy.--(Table  III.)  Strain  n  42,.  Treat- 
ment:  0.45  cc.  of  a  2  per cent solution  of  ethylhydrocuprein in  oil,  per  20 gm. of 
mouse, and 0.2 cc.  of antipneumocoecus serum II. 
TABLE  III. 
Mouse 
No. 
I 
2 
3 
4 
5 
6 
7 
8 
9 
IO 
lI 
I2 
I3 
14 
15 
16 
17 
18 
Dose of cul-  2d day. 
ture. 
¢C. 
0.08  ~  11 
,J 
6, 
O.I  ,, 
i, 
0.2 
3  d day. 
wen 
X 
Well 
4th day._  sth day.  6th day. 
W?ll  I  Well  I  W~ll 
Well  " 
7th day.  8th day. 
W2ll  Well. 
Experiment  3  a.  Controls  to  Experiment  3.--Table  IV  shows  (I)  controls 
infected,  and treated  with o.2 ec.  of antipneumococcus serum alone;  (2)  controls 
of virulence, x 
TABLE  IV. 
(x)  Controls treated witho.2 cc.  of antipneumococcus  serum alone.  (2)  Controls of virulence. 
~,louse  No.  Dose of culture.  Result.  Result. 
o.o6 
d* 
0.08 
0.I 
• 24 hrs. 
• 48 
•  24 
•  "  I 
Mouse No.  Dose of culture. 
C¢. 
I  O.O000I 
2  0.000001 
3 
4  4, 
•  48 hrs. 
1 For  controls  treated  with  ethylhydrocuprein  see  Experiment  2. 394  Chemoserotherapy  of Experimental Pneumococcal  Infection. 
Comment  on Experiments  3  and  3  a.--8  of  IO  animals  infected 
with 0.08 cc.  of culture and  treated  with 0.45  cc.  of the 2  per cent 
solution of the drug and  0.2  cc.  of serum  (each  of which of itself 
is  without effect with this  dose of culture)  survived.  One animal 
died  on  the  third  day  and  pneumococci  were  not  recovered  from 
the  heart's  blood.  The  remaining  animal  died  of  pneumococcal 
septicemia on the fifth day  (delayed death).  All the mice infected 
with o.i  cc.  of culture  and  similarly  treated  survived;  5  °  per  cent 
of the series infected with 0.2 cc. of culture and also similarly treated 
died  of  pneumococcal  septicemia;  the  others  survived.  The  con- 
trol animals  all died of pneumococcal septicemia within  forty-eight 
hours. 
Experiment 4.  Combined  Therapy.  --(Table  V.)  Strain II 433.  Treatment: 
0.45  cc.  of a  2  per cent solution of  ethylhydrocuprein in  oil per 20 gin.  of mouse, 
and 0.2 cc. of antipneumococcus serum II. 
TABLE V. 
Mouse No.  Dose of cul-  2d day.  3d day.  4th day.  sth day.  6th day. 
ture. 
I 
2 
3 
4 
5 
6 
7 
8 
9 
IO 
II 
I2 
13 
14 
CC. 
0.3 
4. 
0.5 
J~ 
,J 
0.7 
0.8 
,, 
Well 
,s 
Sick 
Well 
Well 
it 
Well 
,i 
,L 
+  (eaten) 
Well 
+  (eaten) 
Well 
Well 
Well 
4* 
Sick 
Well  Well. 
,6 
Comment on Experiment 4.--In this experiment in which a larger 
dose  of  infection  was  given than  in  Experiment  3  the  results  did 
not come out uniformly or clear.  The majority of the animals died, 
although in most cases death was delayed.  We thought that a small 
dose  of  optochin  given  on the  second  day might  serve to tide  the 
animals  over  the  third  and  fourth  days  and  so  help  ultimate  re- Henry  F.  Moore.  395 
covery; the result of this modification in dosage of the drug is shown 
in the  next experiment.  Virulence  controls  were  done,  as  in  Ex- 
periment 3 a, but are not shown in the table. 
Experiment 5.  Combined Therapy.--(Table VI.)  Strain II 436.  Treatment: 
0.45  cc. of 2  per cent ethylhydrocnprein  in oil immediately after infection  and 0.4 
cc.  after  24  hours'  interval  per  20  gin.  of  mouse;  0.2  cc.  of  antipneumococcus 
serum  II  at the time of  infection. 
TABLE  VI. 
Mouse  No.  iI)ose  of culture.  2d  day,  3 d  day.  4th  day.  5th  day.  6th  day. 
4 
5 
6 
7 
8 
9 
IO 
II 
I2 
13 
14 
15 
16 
17 
CC. 
0.3 
66 
I, 
0.5 
,i 
,* 
,* 
Well 
Sick 
Well 
al 
Sick 
Well 
*l 
-[- (eaten) 
Well 
Sick 
+  (eaten) 
Well 
i, 
u 
Well 
Well 
X 
Well 
Well. 
,6 
Comment on Experiment 5.--5 °  per cent of the animals infected 
with  0. 3  cc.  of  culture,  and  treated  as  stated,  survived;  of  those 
that  died,  pneumococci  were  not  recovered  from  the  heart's  blood 
of  one;  one  was  eaten  by  its  fellows  and  could  not,  therefore,  be 
autopsied;  two  gave  positive  blood  cultures.  In  the  case  of  in- 
fection  with  0.5  cc.  of  culture,  only two  animals  recovered;  pne  u- 
mococci were recovered  from the heart's blood of all those that died 
except one,  the body of which was so far eaten  that it could not be 
bacteriologically  examined.  In this  experiment  the  altered  dosage 
of the drug ensured a better  result than in the  former case,  but it is 
evident  that  we  are  at the  limit of  protective  power  for  the  condi- 
tions  obtaining  therein.  Consequently  we  proceeded  to  study  the 
effect  of  a  single  larger  dose  of  drug  combined  with  the  serum 
therapy;  namely, 0. 5 cc.  of the 2 per cent oily solution per 20 grams 
of mouse.  Virulence controls were done, as in Experiment 3 a, but 
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Experiment 6.  Combined Therapy.--(Table VII.)  Strain II444.  Treatment: 
o.5  cc.  of 2  per  cent  ethylhydrocuprein base  in  oil  per 2o gm.  of  mouse,  and  o.2 
cc.  of  antipneumococcus  serum  II. 
TABLE  Vll. 
Mouse 
No. 
9 
I0 
II 
12 
13 
14 
I5 
16 
17 
I8 
19 
20 
21 
22 
23 
24 
25 
cDu~tSer°.f  "  2d day. 
~.,c2  Well 
,6 
+  (eaten) 
¢ 
3 d  day. 
V~ dl 
4th day. 
Well 
r 
q  x  J 
5th day.  _ 
Well  Well 
ii 
+  (c  ten) 
V~  11 
6th day.  7th day. 
Well 
,i 
i, 
,J 
ii 
,6 
d, 
+(eatenl 
L 
8th day. 
Well. 
,, 
4* 
'i 
4, 
Two  mice infected with o.ooo~I  cc.  and  one with o.ooooi  cc.  of Strain  II  444 
(controls  of  virulence)  died  of  pneumococcal  septicemia  in  thirty-six  hours. 
Thirteen controls infected with 0.08 cc. of culture  and  treated with o.5  cc. of the 
ethylhydrocuprein  solution  alone  immediately  after  the infection all  died  on  the 
third  day  (forty-eight hours  after  infection)  from pneumococcal  septicemia. 
Comment on L~xperiment  6.--In this case we increased the single 
dose of ethylhydrocuprein to 0. 5 cc. of the 2 per cent solution of the 
base  in oil per 20 grams  of mouse.  Six of eight animals  infected 
with 0.2 cc. of culture, and six of eight animals infected with 0. 3 cc. 
of culture, and  treated as  stated,  survived.  The  four mice  which 
died were eaten by their fellows and therefore could not be autop- 
sied;  in  three  of  these  cases  death  was  delayed  (fourth and  fifth Henry  F.  Moore.  397 
days).  Of  the  nine  animals  infected  with  0.4  cc.  of  culture,  six 
survived;  one  died  on  the  second  day  with  a  sterile  heart's  blood 
(abundant  inoculation)  but pneumococci were  recovered  from  the 
peritoneal  cavity;  one died on the  fourth day and  showed a  sterile 
heart's  blood on  cultivation;  and  one  was  eaten  by its  fellows on 
the  seventh  day.  The  thirteen  controls  infected  with  o.o8  cc.  of 
culture and treated with the dose of drug used in the actual experi- 
ment all died in forty-eight hours, pneumococci being present in the 
heart's  blood of all.  These controls are not shown in the protocol. 
Experiment  7.  Combined  Therapy.--(Table  VIII.)  Strain  II  453.  Treat- 
ment:  0.5  cc.  of  2  per  cent solution  of  ethylhydrocuprein  base  in  oil  per  20  gin. 
of  mouse,  and 0.2 cc.  of antipneumococcus serum  II. 
TABLE  VIII. 
Mouse 
No. 
I 
2 
3 
4 
5 
6 
7 
8 
9 
Io 
II 
I2 
13 
14 
15 
16 
17 
18 
( 
~d day. 
w~11 
I. 
i, 
,L 
Sick 
Sick 
Well 
Sick 
3d day.  4th  day__  5th  day  L 
Well  I  W,,cll  Well 
,i  i, 
6~ 
11  " 
S  Sick  • 
6th day. 
Well 
7th day.  8th day. 
W~ll l we11,,,,,, 
Three  virulence  controls  (O.OOOOOI CC.) all  died  in  forty-eight  hours of  pneu- 
mococcal  septicemia. 
Comment  on  Experiment  7.--All  the  animals  infected  with  0.4 
cc. of culture and treated, and all but one infected with 0. 5 cc. of cul- 
ture and treated,  survived; from the heart's  blood of the one which 
died  (fourth  day)  pneumococci  were  recovered.  5 °  per  cent  of 
those  infected  with  0.6  cc.  of  culture  and  treated  survived;  the 398  Chemoserotherapy of Experimental  Pneumococcal Infection. 
remainder  died  of  pneumococcal  septicemia  (third  tc  fifth  day). 
We have here,  evidently,  reached  the limit  of protection to be got- 
ten  by the  simultaneous  administration  of  antiserum  and  drug  in 
the  manner  and  quantities  indicated  above. 
In addition to the  experiment  mentioned  above, we have carried 
out a series of experiments in which the mice were treated with ethyl- 
hydrocuprein  and  a  non-homologous  serum.  For  example,  we 
have  used an antiserum  to pneumococcus  of Type I  in  the  case of 
infection  with  from  o.oooI  cc.  to  o.x  cc.  of  a  broth  culture  of  a 
virulent  pneumococcus  of  Type  II  (Strain  II  342°),  the  minimal 
lethal dose of which was o.oooooI cc. ;  and we have given the ethyl- 
hydrocuprein  solution  both  as  one  dose  (o. 5  cc.)  at  the  time  of 
infection,  and  as  three  doses on the three  first days  of  the  experi- 
ment  (o.25 cc., o.25  co., and o.z co.), the administration  of the first 
dose  following  the  infection  immediately;  by thus  combining  the 
drug treatment  with non-homologous  serum  therapy,  we have seen 
no  effect  such  as  we  have  described  above  when  the  serum  was 
homologous.  Again,  in  the  case of  treatment  of  infection  with  a 
virulent  strain  of  Group  IV  (Strain  IV  A  67.II3),  the  minimal 
lethal dose of which was o.oooooI cc., we have had no such success 
on giving the drug and a  potent antiserum to pneumococci of either 
Group I  or Group II.  The protocols of these experiments need not 
be exhibited. 
DISCUSSION  OF  RESULTS. 
The  results  of this  study of the treatment  of experimental  pneu- 
mococcal infection in the mouse by simultaneous  administration  of 
ethylhydrocuprein and antipneumococcus serum are clear.  The pro- 
tocols show that o. 5 co. of a  2 per cent oily solution of ethylhydro- 
cuprein  (optochin base), or o.2 ce. of the type homologous antiserum, 
are  each,  by themselves,  powerless to protect  against  o.o6 ce.  of a 
highly virulent  culture of a pneumococcus of Group II;  but that  if 
both  these  bodies,  which  are  chemically  far  removed  from  each 
other, be exhibited simultaneously, protection is given to the animal 
against  as  large  a  dose  of  infection  as  o.5  cc.  of  culture.  The 
potency of the  antiserum  of Type II  is  such  that  o.2 cc.  confers a 
certain  protection  on  mice  against  simultaneous  infection  with  an 
amount  of a  virulent  culture  lying somewhere between o.ooI  cc.  to Henry  F.  Moore.  399 
o.oi  cc. ; with a higher dosage of culture this protection is quite un- 
certain, while it is altogether absent in the case of infection with o.o6 
cc.  of culture.  The dose of ethylhydrocuprein  generally used in the 
present study  (o.5  cc.  of the 2  per  cent  solution)  is  unable  to  pro- 
tect  against a  dose of  infection  as small as o.oooi  co.  of  a  virulent 
culture.  Hence,  the exhibition of such a  small dose of this drug as 
o.5  cc.of  the 2  per eclat solution  (o.oi  of a  gram)  per 2o grams of 
mouse is  capable  of  raising  the  threshold  value of the serum more 
than fifty times;  that is to say,  mice are protected against o.5  cc.  of 
a  virulent  culture by the  combined  therapy,  while  o.2  cc.  of  serum 
alone will not invariably protect against o.oi  cc.  of culture,  and the 
dose  of  ethylhydrocuprein  used  does  not  even  protect  against  five 
thousand  times  less  than  o.5  cc.  of  culture.  Thus  the  protective 
value  of  simultaneous  administration  of  the  drug  and  serum,  even 
though they be given by different routes, is many times greater than, 
TABLE  IX. 
Combined Ethylhydrocuprein  and Serum  Therapy. 
Type II Antiserum.  Pneumococcus,  Stock Strain of Group  II. 
Culture. 
C¢. 
0.001 
0.01 
0.02 
0.04 
o.o6 
o.o8 
o.o8 
,, 
o.oooi 
o.o8 
o.i 
0.2 
0.3 
0.2 
0.3  i 
0.4 
0.5 
0.6 
Ethylhydro- 
cuprem 2 
per cent 
solution. 
CC. 
0.45 
o.5 
o.45 
O.5 
Antiserum 
II. 
¢¢. 
0.2 
m 
m 
0.2 
16 
0.2 
Normal horse 
serum. 
CC. 
0.2 
0.2 
m 
m 
Survivals. 
#ercent 
ioo 
66.6 
4o 
60 
o 
o 
o 
o 
o 
o 
o 
8o 
IOO 
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and  out  of  all  proportion  to,  the  protective  value  of  either  alone. 
The preceding epitome of the results (Table IX) will make this clear. 
It is important to note that, where a non-homologous antiserum is 
used in this combined method, e. 9., a Type I antiserum with a pneu- 
mococcus of Group II or a Type I  or II antiserum with a  pneumo- 
coccus of Group IV,  no such effect as that just stated is seen.  In- 
deed, no more effect is  obtained than if normal,  and not immune, 
serum  be  used.  It  seems  that,  if  the  dose  of  ethylhydrocuprein 
given in the first instance be below a  certain quantity in relation to 
the amount of the infection, subsequent readministration of the drug 
on the next day is  powerless to prevent a  fatal result  from pneu- 
mococcal septicemia. 
CONCLUSIONS. 
I.  A  single  small  dose  of  ethylhydrocuprein  (optochin  base), 
which by itself has  practically no protective effect against experi- 
mental pneumococcal infection in mice, is capable of increasing the 
threshold  value  of  the  type  homologous  antipneumococcus  serum 
at least fifty times. 
2.  This effect is proportionately many times greater than a simple 
summation of the protective effects of these two bodies. 
3-  No such effect is obtained when the antiserum used is one pro- 
duced against a  strain  of pneumococcus  from a  group  other  than 
that to which the infecting pneumococcus belongs. 
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